SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 1,213.69 |
Enterprise Value ($M) | 1,122.47 |
Book Value ($M) | 110.52 |
Book Value / Share | 1.31 |
Price / Book | 10.98 |
NCAV ($M) | 71.84 |
NCAV / Share | 0.85 |
Price / NCAV | 16.89 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.53 |
Return on Assets (ROA) | -1.01 |
Return on Equity (ROE) | -2.53 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 6.33 |
Current Ratio | 6.33 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 214.21 |
Assets | 252.89 |
Liabilities | 142.37 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Manning Paul B | 7.90 | 5.54 | |
13G | BlackRock, Inc. | 5.00 | 0.00 | |
13D/A | Caligan Partners LP | 9.80 | 16.06 | |
13G | Legend Aggregator, LP | 9.50 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
142,666 | 562,796 | 25.35 | |
154,717 | 988,544 | 15.65 | |
161,815 | 723,256 | 22.37 | |
120,486 | 475,921 | 25.32 | |
(click for more detail) |
Similar Companies | |
---|---|
LIXT – Lixte Biotechnology Holdings, Inc. | LPCN – Lipocine Inc. |
LPTX – Leap Therapeutics, Inc. | LSTA – Lisata Therapeutics, Inc. |
LTRN – Lantern Pharma Inc. |
Financial data and stock pages provided by
Fintel.io